Kazia Therapeutics (KZIA) Other Working Capital Changes (2016 - 2022)
Kazia Therapeutics' (KZIA) quarterly Other Working Capital Changes came in at -$412875.1 in Q4 2022, down 305.62% YoY from $200799.6 in Q4 2021, and down 305.62% on a QoQ basis from $200799.6 in Q4 2021.
Kazia Therapeutics (KZIA) Other Working Capital Changes (2016 - 2022) Analysis & Trends
Kazia Therapeutics (KZIA) has 3 years of Other Working Capital Changes data on file, last reported at $111501.4 in Q4 2021.
- Quarterly Other Working Capital Changes fell 305.62% year-over-year to -$412875.1 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$887028.4 (down 89.65% YoY) and the FY2025 annual result came in at $64043.3, down 90.66% from the prior year.
- Other Working Capital Changes slipped to -$412875.1 in Q4 2022, from $200799.6 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $200799.6 in Q4 2021 to a low of -$803674.5 in Q4 2020.
- A 4-year average of -$221757.1 and a median of -$142076.7 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 113.87% in 2021, down 113.87% in 2021.
- Tracing KZIA's Other Working Capital Changes over 4 years: stood at $128721.7 in 2019, then tumbled by 724.35% to -$803674.5 in 2020, then jumped by 124.99% to $200799.6 in 2021, then tumbled by 305.62% to -$412875.1 in 2022.
- The last three Other Working Capital Changes figures came in at -$412875.1 (Q4 2022), $200799.6 (Q4 2021), and -$803674.5 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -412,875.13 |
| Dec 31, 2022 | -412,875.13 |
| Dec 31, 2022 | -412,875.13 |
| Dec 31, 2021 | 200,799.57 |
| Dec 31, 2021 | 200,799.57 |
| Dec 31, 2021 | 200,799.57 |
| Dec 31, 2020 | -803,674.48 |
| Dec 31, 2020 | -803,674.48 |
| Dec 31, 2020 | -803,674.48 |
| Dec 31, 2019 | 128,721.67 |
| Dec 31, 2019 | 128,721.67 |
| Dec 31, 2019 | 128,721.67 |
| Dec 31, 2016 | 6,440.11 |
| Dec 31, 2016 | 6,440.11 |
| Dec 31, 2016 | 6,440.11 |